Approach to the pediatric patient with Graves' disease: When is definitive therapy warranted?

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages 580-588

  Bauer, Andrew J ^a,b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THIAMAZOLE;

ADOLESCENT; CASE REPORT; CHILD CARE; CONCENTRATION LOSS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; FAMILY HISTORY; FATIGUE; FEMALE; FOLLOW UP; GOITER; GRAVES DISEASE; HEART PALPITATION; HEART RATE; HEAT INTOLERANCE; HUMAN; HYPERTHYROIDISM; INCREASED APPETITE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; SYMPTOM;

ADOLESCENT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; CHILD; FEMALE; GOITER; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; IODINE RADIOISOTOPES; METHIMAZOLE; SCHOOLS;

EID: 79952309008     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0898     Document Type: Review

References (65)

1. Zimmerman D, Lteif AN 1998 Thyrotoxicosis in children. Endocrinol Metab Clin North Am 27:109-126 (Pubitemid 28144958)
2. Poyrazoolu S, Saka N, Bas F, Isguven P, Dogu A, Turan S, Bereket A, Turan A, Sarikaya S, Adal E, Cizmecioglu F, Cizmeci F, Saglam H, Ercan O, Memioglu N, Günöz H, Bundak R, Darendeliler F, Yildiz M, Guran T, Akcay T, Akin L, Hatun S 2008 Evaluation of diagnosis and treatment results in children with Graves' disease with emphasis on the pubertal status of patients. J Pediatr Endocrinol Metab 21:745-751
3. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M 2000 Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal patients. J Clin Endocrinol Metab 85:3678-3682
4. Shulman DI, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW 1997 Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 7:755-760 (Pubitemid 28086207)
5. Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM 1999 Special features of Graves' disease in early childhood. Thyroid 9:871-877 (Pubitemid 29480754)
6. Wong GW, Lai J, Cheng PS 1999 Growth in childhood thyrotoxicosis. Eur J Pediatr 158:776-779 (Pubitemid 29448463)
7. Lavard L, Ranløv I, Perrild H, Andersen O, Jacobsen BB 1994 Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur J Endocrinol 130:565-568
8. Rivkees SA, MattisonDR2009 Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009:132041
9. Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, Léger J 2008 Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 93:3817-3826
10. Wasniewska M, Corrias A, Messina MF, Crisafulli G, Salzano G, Valenzise M, Mussa A, De Luca F 2010 Graves' disease prevalence in a young population with Turner syndrome. J Endocrinol Invest 33:69-70
11. Michels AW, Eisenbarth GS 2010 Immunologic endocrine disorders. J Allergy Clin Immunol 125:S226-237
12. De Luca F, Corrias A, Salerno M, Wasniewska M, Gastaldi R, Cassio A, Mussa A, Aversa T, Radetti G, Arrigo T 2010 Peculiarities of Graves' disease in children and adolescents with Down's syndrome. Eur J Endocrinol 162:591-595
13. Birrell G, Cheetham T 2004 Juvenile thyrotoxicosis; can we do better? Arch Dis Child 89:745-750
14. Taylor JC, Gough SC, Hunt PJ, Brix TH, Chatterjee K, Connell JM, Franklyn JA, Hegedus L, Robinson BG, Wiersinga WM, Wass JA, Zabaneh D, Mackay I, Weetman AP 2006 A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab 91:646-653 (Pubitemid 43236938)
15. Kaguelidou F, Carel JC, Léger J 2009 Graves' disease in childhood: advances in management with antithyroid drug therapy. Horm Res 71:310-317
16. Ajjan RA, Weetman AP 2008 Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 4:461-468
17. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126
18. Bossowski AT, Reddy V, Perry LA, Johnston LB, Banerjee K, Blair JC, Savage MO 2007 Clinical and endocrine features and long-term outcome of Graves' disease in early childhood. J Endocrinol Invest 30:388-392 (Pubitemid 47098233)
19. Cassio A, Corrias A, Gualandi S, Tato' L, Cesaretti G, Volta C, Weber G, Bona G, Cappa M, Bal M, Bellone J, Cicognani A 2006 Influence of gender and pubertal stage at diagnosis on growth outcome in childhood thyrotoxicosis: results of a collaborative study. Clin Endocrinol (Oxf) 64:53-57
20. Glaser NS, Styne DM 2008 Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study. Pediatrics 121:e481-e488
21. Nabhan ZM, Kreher NC, Eugster EA 2005 Hashitoxicosis in children: clinical features and natural history. J Pediatr 146:533-536 (Pubitemid 40469719)
22. Zimmermann M, Saad A, Hess S, Torresani T, Chaouki N 2000 Thyroid ultrasound compared with World Health Organization 1960 and 1994 palpation criteria for determination of goiter prevalence in regions of mild and severe iodine deficiency. Eur J Endocrinol 143:727-731
23. Cappelli C, Braga M, De Martino E, Castellano M, Gandossi E, Agosti B, Cumetti D, Pirola I, Mattanza C, Cherubini L, Rosei EA 2006 Outcome of patients surgically treated for various forms of hyperthyroidism with differentiated thyroid cancer: experience at an endocrine center in Italy. Surg Today 36:125-130 (Pubitemid 43163393)
24. Pellegriti G, Belfiore A, Giuffrida D, Lupo L, Vigneri R 1998 Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metab 83:2805-2809 (Pubitemid 28493780)
25. Yano Y, Shibuya H, Kitagawa W, Nagahama M, Sugino K, Ito K, Ito K 2007 Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol 157:325-329 (Pubitemid 47603537)
26. Niedziela M, Korman E 2002 Thyroid carcinoma in a fourteenyear-old boy with Graves disease. Med Pediatr Oncol 38:290-291 (Pubitemid 34258429)
27. Rivkees SA 12 July 2010 63 years and 715 days to the "boxed warning": unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol 10.1155/2010/658267
28. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917 (Pubitemid 40300299)
29. Abraham P, Avenell A, McGeoch SC, Clark LF, Bevan JS 2010 Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev 1:CD003420
30. Walter MA, Briel M, Christ-Crain M, Bonnema SJ, Connell J, Cooper DS, Bucher HC, Müller-Brand J, Müller B 2007 Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. BMJ 334:514
31. Laurberg P 2006 Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism? Eur J Endocrinol 155:783-786
32. Barnes HV, Blizzard RM 1977 Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents. J Pediatr 91:313-320 (Pubitemid 8152136)
33. Barrio R, López-Capapé M, Martinez-Badás I, Carrillo A, Moreno JC, Alonso M 2005 Graves' disease in children and adolescents: response to long-term treatment. Acta Paediatr 94:1583-1589 (Pubitemid 41754312)
34. Gorton C, Sadeghi-Nejad A, Senior B 1987 Remission in children with hyperthyroidism treated with propylthiouracil. Long-term results. Am J Dis Child 141:1084-1086 (Pubitemid 18022831)
35. Hamburger JI 1985 Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 60:1019-1024 (Pubitemid 15085138)
36. Raza J, Hindmarsh PC, Brook CG 1999 Thyrotoxicosis in children: thirty years' experience. Acta Paediatr 88:937-941 (Pubitemid 29448255)
37. Vaidya VA, Bongiovanni AM, Parks JS, Tenore A, Kirkland RT 1974 Twenty-two years' experience in the medical management of juvenile thyrotoxicosis. Pediatrics 54:565-570
38. Lippe BM, Landaw EM, Kaplan SA 1987 Hyperthyroidism in children treated with long term medical therapy: twenty-five percent remission every two years. J Clin Endocrinol Metab 64:1241-1245 (Pubitemid 17074785)
39. Sosa JA, Tuggle CT, Wang TS, Thomas DC, Boudourakis L, Rivkees S, Roman SA 2008 Clinical and economic outcomes of thyroid and parathyroid surgery in children. J Clin Endocrinol Metab 93:3058-3065
40. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Tørring O 2008 TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158:69-75 (Pubitemid 351211042)
41. Erbil Y, Ozluk Y, Girip M, Salmaslioglu A, Issever H, Barbaros U, Kapran Y, Ozarmaoan S, Tezelman S 2007 Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab 92:2182-2189 (Pubitemid 46997119)
42. McLeod IK, Arciero C, Noordzij JP, Stojadinovic A, Peoples G, Melder PC, Langley R, Bernet V, Shriver CD 2006 The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid 16:259-265
43. Alía P, Moreno P, Rigo R, Francos JM, Navarro MA 2007 Postresection parathyroid hormone and parathyroid hormone decline accurately predict hypocalcemia after thyroidectomy. Am J Clin Pathol 127:592-597 (Pubitemid 46587473)
44. Higgins KM, Mandell DL, Govindaraj S, Genden EM, Mechanick JI, Bergman DA, Diamond EJ, Urken ML 2004 The role of intraoperative rapid parathyroid hormone monitoring for predicting thyroidectomy-related hypocalcemia. Arch Otolaryngol Head Neck Surg 130:63-67 (Pubitemid 38095431)
45. Sabour S, Manders E, Steward DL 2009 The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia. Otolaryngol Head Neck Surg 141:727-729
46. Read Jr CH, Tansey MJ, Menda Y 2004 A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients. J Clin Endocrinol Metab 89:4229-4233 (Pubitemid 39244416)
47. Safa AM, Schumacher OP 1976 Letter: Follow-up of children treated with 131-I. N Engl J Med 294:54
48. Rivkees SA, Sklar C, Freemark M 1998 Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83:3767-3776
49. Nikiforov Y, Gnepp DR, Fagin JA 1996 Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab 81:9-14 (Pubitemid 26034998)
50. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, Drozdovitch V, Maceika E, Zvonova I, Vlassov O, Bouville A, Goulko G, Hoshi M, Abrosimov A, Anoshko J, Astakhova L, Chekin S, Demidchik E, Galanti R, Ito M, Korobova E, Lushnikov E, Maksioutov M, Masyakin V, Nerovnia A, Parshin V, Parshkov E, Piliptsevich N, Pinchera A, Polyakov S, Shabeka N, Suonio E, Tenet V, Tsyb A, Yamashita S, Williams D 2005 Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst 97:724-732 (Pubitemid 40872379)
51. Krassas GE, Bartalena L, Benbassat C 2010 Graves' ophthalmopathy (GO), are the extrathyroidal manifestations of Graves' disease. Foreword. Pediatr Endocrinol Rev 7(Suppl 2):173
52. Ponto KA, Zang S, Kahaly GJ 2010 The tale of radioiodine and Graves' orbitopathy. Thyroid 20:785-793
53. Chan W, Wong GW, Fan DS, Cheng AC, Lam DS, Ng JS 2002 Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol 86:740-742 (Pubitemid 34713158)
54. Acuna OM, Athannassaki I, Paysse EA 2007 Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease. Trans Am Ophthalmol Soc 105:146-150; discussion 150-151
55. Gogakos AI, Boboridis K, Krassas GE 2010 Pediatric aspects in Graves' orbitopathy. Pediatr Endocrinol Rev 7(Suppl 2):234-244
56. Stocker T, Dehner LP, eds. 1992 Pediatric pathology. 1st ed. Philadelphia: JB Lippincott Company
57. Rivkees SA, Cornelius EA 2003 Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 111:745-749 (Pubitemid 36402897)
58. Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H 2008 Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizin 47:13-17
59. Noh JY, Yasuda S, Sato S, Matsumoto M, Kunii Y, Noguchi Y, Mukasa K, Ito K, Ito K, Sugiyama O, Kobayashi H, Nihojima S, Okazaki M, Yokoyama S 2009 Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab 94:2806-2811
60. Aloush V, Litinsky I, Caspi D, Elkayam O 2006 Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management. Semin Arthritis Rheum 36: 4-9 (Pubitemid 44144499)
61. Kawachi Y, Nukaga H, Hoshino M, Iwata M, Otsuka F 1995 ANCA-associated vasculitis and lupus-like syndrome caused by methimazole. Clin Exp Dermatol 20:345-347
62. Ahmed K, Rao S, Simha V 2010 Antineutrophil cytoplasmic antibody- positive vasculitis in a patient with Graves' disease: cross-reaction between propylthiouracil and methimazole. Endocr Pract 16: 449-451
63. Rivkees SA, Stephenson K, Dinauer C 2010 Adverse events associated with methimazole therapy of Graves' disease in children. Int J Pediatr Endocrinol 2010:176970
64. Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N 2005 Assays for thyroid-stimulating antibodies and thyrotropinbinding inhibitory immunoglobulins in children with Graves' disease. Endocr J 52:505-510 (Pubitemid 41609036)
65. Glaser NS, Styne DM 1997 Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 82:1719-1726 (Pubitemid 127495174)